Lilly Asia Ventures

Lilly Asia Ventures
Last activity: 26.07.2016
Lilly Asia Ventures (LAV) is a leading biomedical venture capital firm headquartered in China, with offices in Shanghai, Hong Kong, and Palo Alto.
Investment Type: Venture Capital

Mentions in press and media 5

10.05.2021Alebund Pharmaceuticals Raises $60 million in Series B Finan...SHANGHAI, May 10, 2021 /PRNewswire/ -- Alebund Pharmaceuticals ("Alebund" or the "Com...en.prnasia...
26.07.2016Gates Foundation leads $14M funding round for Just Biotherap...Just Biotherapeutics CEO and Founding Partner Jim Thomas Seattle-based Just Biotherapeutics said Mo...geekwire.c...
06.01.2016Daily funding roundup - January 6, 2016Flatiron Health bagged $175M; NextCure, Inc. raised $67M; AirCloset received $8M funding Ossia, a
29.10.2015MabSpace Biosciences Completes $15M Series A FinancingMabSpace Biosciences Co., Ltd., a Suzhou, China-based company focused on the discovery and
21.09.2015Daily funding roundup - September 21, 2015Deciphera bagged $75M; Portea raised $37.5M; Just Biotherapeutics secured $15M BidFlyer, an

Reviews 0

Sign up to leave a review

Sign up Log In